1621. Imfinzi-EMEA-H-C-PSUSA-00010723-202304 1622. Braftovi-H-C-PSUSA-00010719-202306 1623. Ninlaro-H-C-PSUSA-00010535-202305 1624. Myfenax H/C/PSUSA/00010550/202305 1625. Sivextro-H-C-PSUSA-00010369-202306 1626. Duloxetine Lilly-H-C-PSUSA-00001187-202308 1627. Teriflunomide Accord-H-C-PSUSA-00010135-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 1628. Anoro Ellipta-H-C-PSR-S-0048: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 1629. Opdualag-H-C-PSUSA-00011018-202403: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 1630. Skyrizi-H-C-PSUSA-00010765-202403 1631. Apretude-H-C-PSUSA-00000116-202403 1632. Ogentys-H-C-PSUSA-00010516-202406 1633. Kinpeygo-H-C-PSUSA-00011007-202312 1634. Mounjaro-H-C-PSUSA-00011019-202311 1635. Tecovirimat SIGA-H-C-PSUSA-00010971-202401 1636. Cosentyx-H-C-PSUSA-00010341-202312 1637. Scintimun-H-C-PSUSA-00000385-202401 1638. Isturisa-H-C-PSUSA-00010820-202401 1639. Prometax-H-C-PSUSA-00002654-202401 1640. Avamys-H-C-PSUSA-00009154-202404 1641. Duaklir Genuair-PSR-0047 1642. Uptravi-H-C-PSUSA-00010503-202312 1643. Evrenzo-H-C-PSUSA-00010955-202406 1644. Fintepla-H-CH-PSUSA-00010907-202406 1645. TOBI Podhaler : H/C/PSUSA/00009315/202406 - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 1646. Qdenga-H-C-PSUSA-00011034-202408 1647. Sogroya-H-C-PSUSA-00010920-202408 1648. Zynlonta-H-C-PSUSA-00011027-202410 1649. Diacomit-PSUSA-00002789-202411 1650. Lemtrada-H-C-003718-PSR-S-0051